Log in

OTCMKTS:RHHBY - Roche Holdings AG Basel Stock Price, Forecast & News

$38.97
+1.49 (+3.98 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$37.93
Now: $38.97
$39.63
50-Day Range
$35.26
MA: $40.96
$44.10
52-Week Range
$31.81
Now: $38.97
$44.77
Volume1.69 million shs
Average Volume5.45 million shs
Market Capitalization$266.85 billion
P/E Ratio15.34
Dividend Yield1.85%
Beta0.52
Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases. The company's diagnostic solutions include blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol and coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring and therapy; electrolytes analysis; emergency medicine; hemostasis, heterogeneous immunochemistry, homogeneous immuno assay, immunology, and infectious disease solutions; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control services; real-time PCR diagnostic systems; urinalysis; and serum work area and workflow solutions. In addition, it offers gene expression, gene sequencing, and real time PCR systems for researchers. The company licenses its products or technologies to third parties. Roche Holding AG has a collaboration agreement with San Francisco-based Syapse to develop software that integrates fragmented clinical, molecular, and data on treatment plans and health outcomes. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Read More
Roche Holdings AG Basel logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RHHBY
CUSIPN/A
CIKN/A
Phone41-61-688-1111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.87 billion
Cash Flow$3.21 per share
Book Value$5.27 per share

Profitability

Miscellaneous

Employees97,735
Outstanding Shares6,848,490,000
Market Cap$266.85 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter.


Roche Holdings AG Basel (OTCMKTS:RHHBY) Frequently Asked Questions

How has Roche Holdings AG Basel's stock been impacted by COVID-19 (Coronavirus)?

Roche Holdings AG Basel's stock was trading at $40.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RHHBY stock has decreased by 4.8% and is now trading at $38.9650. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Roche Holdings AG Basel?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche Holdings AG Basel in the last year. There are currently 1 hold rating, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Roche Holdings AG Basel.

What price target have analysts set for RHHBY?

7 analysts have issued 1-year target prices for Roche Holdings AG Basel's stock. Their forecasts range from $48.00 to $48.00. On average, they anticipate Roche Holdings AG Basel's stock price to reach $48.00 in the next year. This suggests a possible upside of 23.2% from the stock's current price. View analysts' price targets for Roche Holdings AG Basel.

Has Roche Holdings AG Basel been receiving favorable news coverage?

Media headlines about RHHBY stock have been trending positive recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Roche Holdings AG Basel earned a news impact score of 2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutRoche Holdings AG Basel.

Who are some of Roche Holdings AG Basel's key competitors?

What other stocks do shareholders of Roche Holdings AG Basel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Roche Holdings AG Basel investors own include Roche Holding Ltd. Genussscheine (ROG), Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), AT&T (T), Intel (INTC), General Electric (GE), Gilead Sciences (GILD) and Walt Disney (DIS).

Who are Roche Holdings AG Basel's key executives?

Roche Holdings AG Basel's management team includes the following people:
  • Dr. Severin Schwan, CEO & Exec. Director (Age 52)
  • Dr. Alan Hippe, Chief Financial & Information Officer (Age 52)
  • Dr. Gottlieb A. Keller, Gen. Counsel & Corp. Sec. (Age 65)
  • Ms. Cristina A. Wilbur, Head of Group HR (Age 52)
  • Dr. Karl Mahler, Head of Investor Relations

What is Roche Holdings AG Basel's stock symbol?

Roche Holdings AG Basel trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche Holdings AG Basel's major shareholders?

Roche Holdings AG Basel's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mairs & Power INC (0.08%), Schafer Cullen Capital Management Inc (0.02%), Bowen Hanes & Co. Inc. (0.01%), Douglass Winthrop Advisors LLC (0.01%), Riverbridge Partners LLC (0.01%) and Boston Common Asset Management LLC (0.01%).

Which institutional investors are selling Roche Holdings AG Basel stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, Valicenti Advisory Services Inc., Chartwell Investment Partners LLC, Pacer Advisors Inc., Kornitzer Capital Management Inc. KS, Canandaigua National Bank & Trust Co., Osher Van de Voorde Investment Management, and Oxbow Advisors LLC.

Which institutional investors are buying Roche Holdings AG Basel stock?

RHHBY stock was acquired by a variety of institutional investors in the last quarter, including Bowen Hanes & Co. Inc., Wallington Asset Management LLC, Anderson Hoagland & Co., Mairs & Power INC, Ancora Advisors LLC, Tocqueville Asset Management L.P., MAI Capital Management, and Ferguson Wellman Capital Management Inc..

How do I buy shares of Roche Holdings AG Basel?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Roche Holdings AG Basel's stock price today?

One share of RHHBY stock can currently be purchased for approximately $38.97.

How big of a company is Roche Holdings AG Basel?

Roche Holdings AG Basel has a market capitalization of $266.85 billion and generates $61.87 billion in revenue each year. The company earns $13.58 billion in net income (profit) each year or $2.54 on an earnings per share basis. Roche Holdings AG Basel employs 97,735 workers across the globe. View additional information about Roche Holdings AG Basel.

What is Roche Holdings AG Basel's official website?

The official website for Roche Holdings AG Basel is http://www.roche.com/.

How can I contact Roche Holdings AG Basel?

Roche Holdings AG Basel's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]


MarketBeat Community Rating for Roche Holdings AG Basel (OTCMKTS RHHBY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  291 (Vote Outperform)
Underperform Votes:  318 (Vote Underperform)
Total Votes:  609
MarketBeat's community ratings are surveys of what our community members think about Roche Holdings AG Basel and other stocks. Vote "Outperform" if you believe RHHBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHHBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel